A Brighton scientist who helped develop anti-ageing compounds based on those found in red wine and chocolate is to explain how close we are to alleviating and preventing old age degenerative diseases.
Professor Lizzy Ostler, the University of Brighton’s Professor of Chemical Biology in our school, and a member of the University of Brighton’s Centre for Stress and Age-Related Disease, is giving her inaugural lecture on 20 March.
University of Brighton researchers are joining forces with entrepreneurs and community groups to turn Brighton and Hove into a focal point for health interventions.
The social and commercial network in the Brighton and Hove area will be tasked with improving health, accelerating innovation and enhancing competitiveness.
The University’s Healthy Futures will be the platform for new partnerships which will search for and research new disease preventions, diagnoses, pioneering treatments and breakthrough innovations. The collaborations will also foster high-skill training and jobs.
Professor Matteo Santin, Academic Lead for Healthy Futures, said: “We believe that in the long term the city has the potential to emerge as a model city for health enterprise where societal needs are addressed through pioneering approaches and where organisations thrive through public and private investment.
“As a non-profit organisation with a multidisciplinary expertise, our University is in a privileged position to make this happen.”
The academic/business partnerships will first listen to their respective needs and to those of the public. To this end, local companies, entrepreneurs and organisations are being invited to the inaugural Health Entrepreneurs’ Brunch at the Old Ship Hotel in Brighton on 19 December. Two similar events will be held at later dates. Read More →
University of Brighton scientists and partners in Vietnam have made a breakthrough in the delivery of a disease-fighting constituent of the spice turmeric.
Curcumin, extracted from turmeric, has anti-oxidant and anti-inflammatory activities and has been used for the prevention and treatment of cancer, diabetes, neurodegeneration and cardiovascular disease; all diseases linked to ageing. The problem has been finding an effective way of delivering curcumin – but now scientists believe they have found a process that does. Read More →
The university’s School of Pharmacy and Biomolecular Science (PABS) has received a Silver Award from Advance HE’s highly-regarded SWAN Charter, which promotes gender equality in the representation, progression and success of staff and students in Higher Education.
The Silver Award was granted in recognition of actions implemented to advance careers of women in science over the past few years. Read More →
It consists of a dual-screen display that generates real-time digital ‘lifeforms’ from interactions and local data. The design evolves as the data shifts, with the ‘lifeforms’ changing shape and movement. Read More →
The University of Brighton has played a pivotal role in the growth of slime mould for an innovative installation at the Brighton Digital Festival.
Digital artists Cesar Baio and Lucy HG Solomon – who form the collective Cesar & Lois with collaborator Jeremy Speed Schwartz – used the university’s microbiology laboratory to develop the Physarum polychephalum (slime mould) that features in their installation Degenerative Cultures, one element of the wider Uncommon Natures exhibition.
Cesar and Lucy worked closely with the University of Brighton’s Joao Inacio, a senior lecturer in pharmacy and biomolecular sciences, in the course of preparing their microbiological samples for the art display. Joao said: “It was really fun to meet and work with Cesar and Lucy in our lab.”
Uncommon Natures showcases the artists who are finalists of the Lumen Prize for Digital Art, which “celebrates the very best art created with technology”.
Jack Addis, creative director of Lumen Prize, said: “We’re excited to bring together this selection of shortlisted 2018 Lumen Prize artists and to celebrate artists working with a variety of media and mediums.” Read More →
Some bladder cancer patients could be saved from months of unnecessary and ineffective treatment by a simple blood test, according to researchers at Brighton and Sussex Medical School (BSMS), run by Brighton and Sussex universities.
The test would benefit those patients who are unlikely to benefit from a commonly used immunotherapy.
Currently, 30-40 per cent of individuals have no benefit from the standard immunotherapy treatment, and they are only identified once therapy has failed, often six months or longer later. Read More →